| SNP (gene) | Genotype/Allele | MS Patients n = 113 (%) | Controls n = 146 (%) | X² | p | OR (95% CI) | |
| rs2248359 (CYP24A1) | additive genetic model | CC | 28 (24.78) | 44 (30.14) | 1.38 | 0.50 | |
| CT | 59 (52.21) | 66 (45.21) | |||||
| TT | 26 (23.01) | 36 (24.66) | |||||
| dominant genetic model | CC | 28 (24.78) | 44 (30.14) | 0.91 | 0.34 | 0.76 (0.44 - 1.33) | |
| CT + TT | 85 (75.22) | 102 (69.86) | |||||
| recessive genetic model | CC + CT | 87 (76.99) | 110 (75.34) | 0.10 | 0.76 | 0.91 (0.51 - 1.63) | |
| TT | 26 (23.01) | 36 (24.66) | |||||
| allelic model | C | 115 (50.88) | 154 (52.74) | 0.18 | 0.67 | 0.93 (0.65 - 1.31) | |
| T | 111 (49.12) | 138 (47.26) | |||||
| rs703842 (CYP27B1) | additive genetic model | AA | 82 (72.57) | 90 (61.64) | 3.46 | 0.18 | |
| AG | 26 (23.01) | 48(32.88) | |||||
| GG | 5 (4.42) | 8 (5.48) | |||||
| dominant genetic model | AA | 82 (72.57) | 90 (61.64) | 3.41 | 0.07 | 1.65 (0.97 - 2.80) | |
| AG + GG | 31 (27.43) | 56 (38.36) | |||||
| recessive genetic model | AA + AG | 108 (95.58) | 138 (94.52) | 0.15 | 0.70 | 0.80 (0.25 - 2.51) | |
| GG | 5 (4.42) | 8 (5.48) | |||||
| allelic model | A | 190 (84.07) | 228 (78.08) | 2.93 | 0.08 | 1.18 (0.94 - 2.33) | |
| G | 36 (15.93) | 64 (21.92) | |||||